Göm menyn

Publications for Sverre Sörenson

Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 5 times*

Journal Articles

Sverre Sörenson, Helena Fohlin, Andrea Lindgren, Magnus Lindskog, Bengt Bergman, Christer Sederholm, Lars Ek, Kristina Lamberg and Birgitta Clinchy
  Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy
  European Journal of Cancer, 2013, 49(1), 115-120.
   Fulltext  PDF  
 Web of Science® Times Cited: 8

Andrea Koch, Bertil Gustafsson, Helena Fohlin and Sverre Sörenson
  Cyclooxygenase-2 expression in lung cancer cells evaluated by immunocytochemistry
  Diagnostic Cytopathology, 2011, 39(3), 188-193.
 Web of Science® Times Cited: 7

Andrea Koch, Bengt Bergman, Erik Holmberg, Christer Sederholm, Lars Ek, Jaroslaw Kosieradzki, Kristina Lamberg, Lars Thaning, Sven-Olof Ydreborg and Sverre Sörenson
  Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group
  European Journal of Cancer, 2011, 47(10), 1546-1555.
 Web of Science® Times Cited: 24

Andrea Koch, Helena Fohlin and Sverre Sörenson
  Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, 4(3), 326-32.
 Web of Science® Times Cited: 61

Sverre Sörenson
  Svenska lungcancermötet 2009: Ny behandling för komorbida lungcancerpatienter
  Onkologi i Sverige, 2009, (4), 74-77.

MH Cullen, P Zatloukal, Sverre Sörenson, S Novello, JR Fischer, AA Joy, M Zereu, P Peterson, CM Visseren-Gruf and N Iscoe
  A Randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer
  Annals of Oncology, 2008, 19(5), 939-945.
 Web of Science® Times Cited: 53

Christian von Plessen, Trond-Eirik Strand, Tore Wentzel-Larsen, Ernst Omenaas, Nils Wilking, Stein Sundstrøm and Sverre Sörenson
  Effectiveness of third generation chemotherapy on the survival of patients with advanced non-small cell lung cancer - a national study
  Thorax, 2008, , .
 Web of Science® Times Cited: 9

Andreas Hermes, Bengt Bergman, Roy Bremnes, Lars Ek, Sverre Fluge, Christer Sederholm, Stein Sundstrøm, Lars Thaning, Jan Vilsvik, Ulf Aasebø and Sverre Sörenson
  Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial
  Journal of Clinical Oncology, 2008, 26(26), 4261-4267.
 Web of Science® Times Cited: 90

Sverre Sörenson
  Ny indikation för profylaktisk hjärnbestrålning vid småcellig lungcancer?
  Onkologi i Sverige, 2007, (4), 62-63.

C von Plessen, B Bergman, O Andresen, RM Bremnes, S Sundström, M Gilleryd, RM Stephens, J Vilsvik, U Aasebö and Sverre Sörenson
  Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer
  British Journal of Cancer, 2006, 95(8), 966-973.

Michael Bergqvist, Sverre Sörenson, Baniel Brattström, Tony Mok and Roger Henriksson
  Role of non-taxane-containing chemotherapy in advanced non-small cell lung cancer
  American Journal of Cancer, 2006, 5(4), 223-244.

Andrea Koch, Sverre Sörenson, Asgeir Askeland and Tor Aasen
  Rapportering av yrkesrelatert lungekreft.
  Lungeforum, 2003, 13, 12-16.

Conference Articles

Andrea Koch, Sverre Sörenson, H Fohlin and B Gustafsson
  Expression of cyclooxygenase-2 in cytological material from patients with lung cancer in EJC SUPPLEMENTS, vol 7, issue 2, pp 513-513

Ph.D. Theses

Andrea Koch
  Clinical Aspects of Inflammation in Non-small Cell Lung Cancer

  Fulltext PDF


Sverre Sörenson
  Rapport from American Society of Clinical Oncololgy (ASCO)
  Lungeforum, , 2002.

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.


Responsible for this page: Peter Berkesand
Last updated: 2017-02-21